From the Medical School (S.K., J.H.J., A.H.), Renal and Transplantation Unit (S.S., D.B.), and Department of Radiology (U.P.), St George's University Hospitals NHS Foundation Trust, University of London, Blackshaw Rd, London SW17 0QT, England.
Radiology. 2016 Oct;281(1):301-10. doi: 10.1148/radiol.2016151629. Epub 2016 Mar 28.
Purpose To study long-term graft and patient survival after percutaneous ureteroplasty of ureteric stenosis after renal transplantation and to compare the outcomes to those of patients who did not develop ureteric stenosis. Materials and Methods An ethical waiver was obtained for this 23-year retrospective matched cohort study of 52 of 1476 consecutive kidney transplant recipients who developed postoperative ureteric stenosis. Data were collected between January 1990 and December 2012. All patients (mean age, 47 years [range, 23-72 years]; 36 men aged 29-72 years [mean age, 49 years] and 24 women aged 23-68 years [mean age, 42 years]) underwent percutaneous ureteroplasty; recurrent stenosis was managed surgically or by means of long-term ureteric stent placement. Outcomes were compared with those of a matched control group of transplant recipients with no history of ureteric stenosis. Primary outcome measures were death-censored graft failure and all-cause mortality. Secondary outcome measures were the effect of time of stricture onset on graft survival, complications, and risk factors for recurrent stenosis. Kaplan-Meier curves were compared by using log-rank tests, with P < .05 indicative of a statistically significant difference. Results Balloon dilation was technically successful in all 52 strictures, but stenosis recurred in 10 patients and was treated with surgery (n = 5) or long-term stent placement (n = 5). The 10-year graft and patient survival were not significantly different in study versus control groups, with graft survival of 64.5% (95% confidence interval [CI]: 43.4%, 79.4%) versus 76.3% (95% CI: 58.6%, 87.2%), respectively (P = .372), and patient survival of 82.2% (95% CI: 62.9%, 92%) versus 89.9% (95% CI: 74.6%, 96.2%) (P = .632). Subgroup analysis showed that stenosis occurring less than 3 months (10-year graft survival, 59.1%), at least 3 months (10-year graft survival, 67.3%), and at least 6 months (10-year graft survival, 53.0%) after transplantation did not adversely affect graft survival compared with that of the control group (P > .05). Cold ischemia time was longer in those with recurrent stenosis than in control subjects (16.1 vs 8.4 hours, respectively; P = .034). The minor and major complication rates were 13% and 5.7%, respectively, with no 30-day graft loss and patient mortality. Conclusion Long-term graft and patient survival in patients with percutaneous ureteroplasty of transplant ureteric stenosis were not significantly worse than those in a control group. (©) RSNA, 2016.
研究经皮肾移植术后输尿管狭窄患者行输尿管成形术的长期移植物和患者存活率,并与未发生输尿管狭窄的患者的结果进行比较。
本研究为回顾性队列研究,纳入了 1476 例连续肾移植患者中的 52 例(2372 岁),因术后输尿管狭窄行经皮输尿管成形术,共 23 年。数据收集于 1990 年 1 月至 2012 年 12 月。所有患者(平均年龄 47 岁[范围 2372 岁];36 名男性,年龄 2972 岁[平均年龄 49 岁];24 名女性,年龄 2368 岁[平均年龄 42 岁])均接受了经皮输尿管成形术;复发性狭窄采用手术或长期输尿管支架置入治疗。结果与无输尿管狭窄病史的匹配对照组进行比较。主要结局指标为死亡相关移植物失败和全因死亡率。次要结局指标为狭窄发病时间对移植物存活的影响、并发症和复发性狭窄的危险因素。采用对数秩检验比较 Kaplan-Meier 曲线,P<0.05 为差异有统计学意义。
52 例狭窄处球囊扩张技术均成功,但 10 例患者出现狭窄复发,其中 5 例采用手术治疗,5 例采用长期支架置入治疗。研究组和对照组的 10 年移植物和患者存活率无显著差异,移植物存活率分别为 64.5%(95%置信区间:43.4%,79.4%)和 76.3%(95%置信区间:58.6%,87.2%)(P=0.372),患者存活率分别为 82.2%(95%置信区间:62.9%,92%)和 89.9%(95%置信区间:74.6%,96.2%)(P=0.632)。亚组分析显示,狭窄发生在移植后 3 个月内(10 年移植物存活率 59.1%)、至少 3 个月(10 年移植物存活率 67.3%)和至少 6 个月(10 年移植物存活率 53.0%)的患者与对照组相比,移植物存活率无显著差异(P>0.05)。复发狭窄患者的冷缺血时间长于对照组(分别为 16.1 小时和 8.4 小时,P=0.034)。并发症发生率为 13%,主要并发症发生率为 5.7%,无 30 天内移植物丢失和患者死亡。
经皮肾移植术后输尿管狭窄患者行输尿管成形术的长期移植物和患者存活率与对照组相比无显著差异。